PRESS RELEASE published on 04/29/2025 at 15:52, 1 year 4 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses ownership of 5.39% in Direct Line Insurance Group plc as of 28 April 2025 Form 8.3 The Vanguard Group Ownership Disclosure Direct Line Insurance Group Plc Financial Holding
BRIEF published on 04/25/2025 at 16:02, 1 year 4 months ago Vanguard Discloses Position in Direct Line Insurance Group Form 8.3 Takeover Code Vanguard Group Shareholding Direct Line Insurance
BRIEF published on 04/25/2025 at 16:02, 1 year 4 months ago Vanguard révèle sa position dans Direct Line Insurance Group Actionnariat Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Assurance Direct Line
PRESS RELEASE published on 04/25/2025 at 15:57, 1 year 4 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.39% stake in Direct Line Insurance Group plc as of 24 April 2025, along with dealings in ordinary shares Ordinary Shares The Vanguard Group Dealings Stake Direct Line Insurance Group Plc
BRIEF published on 04/24/2025 at 16:07, 1 year 4 months ago Vanguard Group Discloses Positions in Direct Line Insurance Group Form 8.3 Takeover Code Stock Transactions Vanguard Disclosures Direct Line Shares
BRIEF published on 04/24/2025 at 16:07, 1 year 4 months ago Vanguard Group dévoile ses positions dans Direct Line Insurance Group Code De Prise De Contrôle Transactions Boursières Formulaire 8.3 Divulgations De Vanguard Actions De Ligne Directe
PRESS RELEASE published on 04/24/2025 at 16:02, 1 year 4 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.39% stake in Direct Line Insurance Group plc. Recent transactions include purchases and sales of ordinary shares Vanguard Group Financial Disclosure Stake Disclosure Share Transactions Direct Line Insurance
BRIEF published on 04/23/2025 at 15:40, 1 year 4 months ago Vanguard's Position in Direct Line Insurance Group Takeover Code Vanguard Group Shareholding Investment Disclosure Direct Line
BRIEF published on 04/23/2025 at 15:40, 1 year 4 months ago Position de Vanguard dans Direct Line Insurance Group Actionnariat Groupe Vanguard Code De Prise De Contrôle Divulgation D'investissement Ligne Directe
PRESS RELEASE published on 04/23/2025 at 15:35, 1 year 4 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.38% stake in Direct Line Insurance Group plc as of 22 April 2025. Purchased additional securities at 2.77 GBP per unit The Vanguard Group Inc. Financial Disclosure Stake Disclosure Securities Purchase Direct Line Insurance Group Plc
Published on 09/11/2026 at 04:00, 6 hours 7 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 11 hours 42 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 18 hours 47 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 19 hours 7 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 09:20, 47 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 1 hour 2 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 1 hour 7 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 3 hours 7 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 3 hours 7 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 14 hours 37 minutes ago Availability of the 2026 Interim Financial Report
